OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T

NIH RePORTER · NIH · N01 · $1,350,572 · view on reporter.nih.gov ↗

Abstract

OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). This contract is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction. This study will continue to build the evidence-basis for better treatment of opioid misuse and addiction in order to stem the national opioid public health crisis.

Key facts

NIH application ID
10667369
Project number
75N95019D00013-P00002-759502000002-1
Recipient
THE EMMES COMPANY, LLC
Principal Investigator
PAUL VANVELDHUISEN
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$1,350,572
Award type
Project period
2020-03-01 → 2026-02-28